Glenmark Pharmaceuticals Ltd. is a high-risk pharmaceutical company based in India. Specializing in specialty and generic drug manufacturing, Glenmark focuses on ESG research and development to address medical needs. Their product categories include novel molecular entities, formulations, and API products. The company also considers mergers and acquisitions as potential investments for growth.